Serveur d'exploration sur la COVID en France

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Care of the Patient with IBD Requiring Hospitalization During the COVID-19 Pandemic.

Identifieur interne : 001398 ( Main/Exploration ); précédent : 001397; suivant : 001399

Care of the Patient with IBD Requiring Hospitalization During the COVID-19 Pandemic.

Auteurs : Matthieu Allez [France] ; Phillip Fleshner [États-Unis] ; Richard Gearry [Nouvelle-Zélande] ; Peter L. Lakatos [Hongrie] ; David T. Rubin [États-Unis]

Source :

RBID : pubmed:32722757

Abstract

The management of IBD has been highly impacted in the context of the COVID-19 pandemic, with restriction of hospitalizations and unprecedented redeployment of healthcare resources. Hospital admissions of IBD patients should be limited to reduce the risks of coronavirus transmission. However, delaying hospitalization of IBD patients with severe or complicated disease may increase the risk of poor outcomes. Delaying surgery in some cases may increase the risk of disease progression, post-operative morbidity and disease complications. IBD patients who are infected with SARS-CoV-2 may have a higher risk of poor outcomes than the general population, potentially related to concomitant medications, especially corticosteroids. There is no evidence today that IBD patients with COVID-19 have worse outcomes if they receive immunosuppressant medications including thiopurines, biologics and novel small molecules. This article summarizes recommendations by the international membership of IOIBD regarding hospitalizations of IBD patients, either for active or complicated IBD or severe COVID-19, and for management of IBD patients according to SARS-CoV-2 infectious status.

DOI: 10.1093/ecco-jcc/jjaa150
PubMed: 32722757
PubMed Central: PMC7454473


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Care of the Patient with IBD Requiring Hospitalization During the COVID-19 Pandemic.</title>
<author>
<name sortKey="Allez, Matthieu" sort="Allez, Matthieu" uniqKey="Allez M" first="Matthieu" last="Allez">Matthieu Allez</name>
<affiliation wicri:level="1">
<nlm:affiliation>Hôpital Saint-Louis, Department of Gastroenterology, APHP, Université de Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hôpital Saint-Louis, Department of Gastroenterology, APHP, Université de Paris</wicri:regionArea>
<wicri:noRegion>Université de Paris</wicri:noRegion>
<wicri:noRegion>Université de Paris</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Fleshner, Phillip" sort="Fleshner, Phillip" uniqKey="Fleshner P" first="Phillip" last="Fleshner">Phillip Fleshner</name>
<affiliation wicri:level="2">
<nlm:affiliation>Division of Colorectal Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Colorectal Surgery, Cedars-Sinai Medical Center, Los Angeles, CA</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gearry, Richard" sort="Gearry, Richard" uniqKey="Gearry R" first="Richard" last="Gearry">Richard Gearry</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medicine, University of Otago, Christchurch, New Zealand.</nlm:affiliation>
<country xml:lang="fr">Nouvelle-Zélande</country>
<wicri:regionArea>Department of Medicine, University of Otago, Christchurch</wicri:regionArea>
<wicri:noRegion>Christchurch</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lakatos, Peter L" sort="Lakatos, Peter L" uniqKey="Lakatos P" first="Peter L" last="Lakatos">Peter L. Lakatos</name>
<affiliation wicri:level="4">
<nlm:affiliation>McGill University, Division of Gastroenterology Department of Medicine, Montreal, Canada and Semmelweis University, 1st Department of Medicine, Budapest, Hungary.</nlm:affiliation>
<country xml:lang="fr">Hongrie</country>
<wicri:regionArea>McGill University, Division of Gastroenterology Department of Medicine, Montreal, Canada and Semmelweis University, 1st Department of Medicine, Budapest</wicri:regionArea>
<placeName>
<settlement type="city">Budapest</settlement>
<region nuts="2">Hongrie centrale</region>
</placeName>
<orgName type="university">Université McGill</orgName>
</affiliation>
</author>
<author>
<name sortKey="Rubin, David T" sort="Rubin, David T" uniqKey="Rubin D" first="David T" last="Rubin">David T. Rubin</name>
<affiliation wicri:level="2">
<nlm:affiliation>University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, IL, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, IL</wicri:regionArea>
<placeName>
<region type="state">Illinois</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32722757</idno>
<idno type="pmid">32722757</idno>
<idno type="doi">10.1093/ecco-jcc/jjaa150</idno>
<idno type="pmc">PMC7454473</idno>
<idno type="wicri:Area/Main/Corpus">000813</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000813</idno>
<idno type="wicri:Area/Main/Curation">000813</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000813</idno>
<idno type="wicri:Area/Main/Exploration">000813</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Care of the Patient with IBD Requiring Hospitalization During the COVID-19 Pandemic.</title>
<author>
<name sortKey="Allez, Matthieu" sort="Allez, Matthieu" uniqKey="Allez M" first="Matthieu" last="Allez">Matthieu Allez</name>
<affiliation wicri:level="1">
<nlm:affiliation>Hôpital Saint-Louis, Department of Gastroenterology, APHP, Université de Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hôpital Saint-Louis, Department of Gastroenterology, APHP, Université de Paris</wicri:regionArea>
<wicri:noRegion>Université de Paris</wicri:noRegion>
<wicri:noRegion>Université de Paris</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Fleshner, Phillip" sort="Fleshner, Phillip" uniqKey="Fleshner P" first="Phillip" last="Fleshner">Phillip Fleshner</name>
<affiliation wicri:level="2">
<nlm:affiliation>Division of Colorectal Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Colorectal Surgery, Cedars-Sinai Medical Center, Los Angeles, CA</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gearry, Richard" sort="Gearry, Richard" uniqKey="Gearry R" first="Richard" last="Gearry">Richard Gearry</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medicine, University of Otago, Christchurch, New Zealand.</nlm:affiliation>
<country xml:lang="fr">Nouvelle-Zélande</country>
<wicri:regionArea>Department of Medicine, University of Otago, Christchurch</wicri:regionArea>
<wicri:noRegion>Christchurch</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lakatos, Peter L" sort="Lakatos, Peter L" uniqKey="Lakatos P" first="Peter L" last="Lakatos">Peter L. Lakatos</name>
<affiliation wicri:level="4">
<nlm:affiliation>McGill University, Division of Gastroenterology Department of Medicine, Montreal, Canada and Semmelweis University, 1st Department of Medicine, Budapest, Hungary.</nlm:affiliation>
<country xml:lang="fr">Hongrie</country>
<wicri:regionArea>McGill University, Division of Gastroenterology Department of Medicine, Montreal, Canada and Semmelweis University, 1st Department of Medicine, Budapest</wicri:regionArea>
<placeName>
<settlement type="city">Budapest</settlement>
<region nuts="2">Hongrie centrale</region>
</placeName>
<orgName type="university">Université McGill</orgName>
</affiliation>
</author>
<author>
<name sortKey="Rubin, David T" sort="Rubin, David T" uniqKey="Rubin D" first="David T" last="Rubin">David T. Rubin</name>
<affiliation wicri:level="2">
<nlm:affiliation>University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, IL, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, IL</wicri:regionArea>
<placeName>
<region type="state">Illinois</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of Crohn's & colitis</title>
<idno type="eISSN">1876-4479</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The management of IBD has been highly impacted in the context of the COVID-19 pandemic, with restriction of hospitalizations and unprecedented redeployment of healthcare resources. Hospital admissions of IBD patients should be limited to reduce the risks of coronavirus transmission. However, delaying hospitalization of IBD patients with severe or complicated disease may increase the risk of poor outcomes. Delaying surgery in some cases may increase the risk of disease progression, post-operative morbidity and disease complications. IBD patients who are infected with SARS-CoV-2 may have a higher risk of poor outcomes than the general population, potentially related to concomitant medications, especially corticosteroids. There is no evidence today that IBD patients with COVID-19 have worse outcomes if they receive immunosuppressant medications including thiopurines, biologics and novel small molecules. This article summarizes recommendations by the international membership of IOIBD regarding hospitalizations of IBD patients, either for active or complicated IBD or severe COVID-19, and for management of IBD patients according to SARS-CoV-2 infectious status.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="Publisher" Owner="NLM">
<PMID Version="1">32722757</PMID>
<DateRevised>
<Year>2020</Year>
<Month>09</Month>
<Day>01</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1876-4479</ISSN>
<JournalIssue CitedMedium="Internet">
<PubDate>
<Year>2020</Year>
<Month>Jul</Month>
<Day>29</Day>
</PubDate>
</JournalIssue>
<Title>Journal of Crohn's & colitis</Title>
<ISOAbbreviation>J Crohns Colitis</ISOAbbreviation>
</Journal>
<ArticleTitle>Care of the Patient with IBD Requiring Hospitalization During the COVID-19 Pandemic.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">jjaa150</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/ecco-jcc/jjaa150</ELocationID>
<Abstract>
<AbstractText>The management of IBD has been highly impacted in the context of the COVID-19 pandemic, with restriction of hospitalizations and unprecedented redeployment of healthcare resources. Hospital admissions of IBD patients should be limited to reduce the risks of coronavirus transmission. However, delaying hospitalization of IBD patients with severe or complicated disease may increase the risk of poor outcomes. Delaying surgery in some cases may increase the risk of disease progression, post-operative morbidity and disease complications. IBD patients who are infected with SARS-CoV-2 may have a higher risk of poor outcomes than the general population, potentially related to concomitant medications, especially corticosteroids. There is no evidence today that IBD patients with COVID-19 have worse outcomes if they receive immunosuppressant medications including thiopurines, biologics and novel small molecules. This article summarizes recommendations by the international membership of IOIBD regarding hospitalizations of IBD patients, either for active or complicated IBD or severe COVID-19, and for management of IBD patients according to SARS-CoV-2 infectious status.</AbstractText>
<CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Allez</LastName>
<ForeName>Matthieu</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Hôpital Saint-Louis, Department of Gastroenterology, APHP, Université de Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fleshner</LastName>
<ForeName>Phillip</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Division of Colorectal Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gearry</LastName>
<ForeName>Richard</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, University of Otago, Christchurch, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lakatos</LastName>
<ForeName>Peter L</ForeName>
<Initials>PL</Initials>
<AffiliationInfo>
<Affiliation>McGill University, Division of Gastroenterology Department of Medicine, Montreal, Canada and Semmelweis University, 1st Department of Medicine, Budapest, Hungary.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rubin</LastName>
<ForeName>David T</ForeName>
<Initials>DT</Initials>
<AffiliationInfo>
<Affiliation>University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, IL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<CollectiveName>IOIBD</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>07</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Crohns Colitis</MedlineTA>
<NlmUniqueID>101318676</NlmUniqueID>
<ISSNLinking>1873-9946</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>06</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>7</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>7</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>7</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32722757</ArticleId>
<ArticleId IdType="pii">5877455</ArticleId>
<ArticleId IdType="doi">10.1093/ecco-jcc/jjaa150</ArticleId>
<ArticleId IdType="pmc">PMC7454473</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>France</li>
<li>Hongrie</li>
<li>Nouvelle-Zélande</li>
<li>États-Unis</li>
</country>
<region>
<li>Californie</li>
<li>Hongrie centrale</li>
<li>Illinois</li>
</region>
<settlement>
<li>Budapest</li>
</settlement>
<orgName>
<li>Université McGill</li>
</orgName>
</list>
<tree>
<country name="France">
<noRegion>
<name sortKey="Allez, Matthieu" sort="Allez, Matthieu" uniqKey="Allez M" first="Matthieu" last="Allez">Matthieu Allez</name>
</noRegion>
</country>
<country name="États-Unis">
<region name="Californie">
<name sortKey="Fleshner, Phillip" sort="Fleshner, Phillip" uniqKey="Fleshner P" first="Phillip" last="Fleshner">Phillip Fleshner</name>
</region>
<name sortKey="Rubin, David T" sort="Rubin, David T" uniqKey="Rubin D" first="David T" last="Rubin">David T. Rubin</name>
</country>
<country name="Nouvelle-Zélande">
<noRegion>
<name sortKey="Gearry, Richard" sort="Gearry, Richard" uniqKey="Gearry R" first="Richard" last="Gearry">Richard Gearry</name>
</noRegion>
</country>
<country name="Hongrie">
<region name="Hongrie centrale">
<name sortKey="Lakatos, Peter L" sort="Lakatos, Peter L" uniqKey="Lakatos P" first="Peter L" last="Lakatos">Peter L. Lakatos</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001398 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001398 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32722757
   |texte=   Care of the Patient with IBD Requiring Hospitalization During the COVID-19 Pandemic.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32722757" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidFranceV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021